IGIM
IONS icon

I.G. Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

I.G. Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-489
Closed -$18K – 569
2016
Q3 		$18K Hold
489
– – ﹤0.01% 874
2016
Q2 		$11K Hold
489
– – ﹤0.01% 882
2016
Q1 		$20K Buy
+489
New +$19.9K ﹤0.01% 891

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

I.G. Investment Management's IONS Position: Q4 2016 in Review

I.G. Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2016, closing a stake of 489 shares — an estimated $18K sold.

I.G. Investment Management first reported a position in IONS in Q1 2016 and held it in 3 quarters. The position peaked at $20K in Q1 2016. 308 funds tracked by Wall St. Rank hold IONS as of Q4 2016.

  • I.G. Investment Management reported no remaining Ionis Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • I.G. Investment Management sold 489 Ionis Pharmaceuticals shares in Q4 2016, an estimated $18K.
  • I.G. Investment Management first reported a position in Ionis Pharmaceuticals in Q1 2016 and held it in 3 quarters.
  • I.G. Investment Management's Ionis Pharmaceuticals position peaked at $20K in Q1 2016.
  • 308 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2016.

Based on I.G. Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.